Acute Porphyria Drug Database

Monograph

A10BD20 - Metformin and Empagliflozin
Propably not porphyrinogenic
PNP

Rationale
Combination of two substances classified as NP (metformin) and PNP (empagliflozin). For more extensive monographs, please search the individual substances metformin (ATC A10BA02) and dapagliflozin (ATC A10BX09) in this database.
Chemical description
Metformin is a biguanide antidiabetic. Empagliflozin is a selective and reversible inhibitor of sodium-glucose co-transporter 2 (SGLT2).

Similar drugs
Explore alternative drugs in similar therapeutic classes A10B / A10BD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Synjardy · Synjardy 12,5 mg/1000 mg filmomhulde tabletten · Synjardy 12,5 mg/850 mg filmomhulde tabletten · Synjardy 5 mg/1000 mg filmomhulde tabletten · Synjardy 5 mg/850 mg filmomhulde tabletten
Belgium
Synjardy · Synjardy 12.5 mg - 1 000 mg compr. pellic. · Synjardy 12.5 mg - 850 mg compr. pellic. · Synjardy 5 mg - 1 000 mg compr. pellic. · Synjardy 5 mg - 850 mg compr. pellic.
United Kingdom
Synjardy · Synjardy 12.5mg/1000mg tablets · Synjardy 12.5mg/850mg tablets · Synjardy 5mg/1000mg tablets · Synjardy 5mg/850mg tablets
Denmark
Synjardy
Norway
Synjardy
Poland
Synjardy
Luxembourg
Synjardy
Iceland
Synjardy
Finland
Synjardy
Latvia
Synjardy
Serbia
Synjardy · Synjardy®
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙